In addition, since the first evidence of a beneficial effect of GLP-1RAs in BAD treatment was not available until 2019, we notice that the prescriptions of GLP-1RAs up until this year were made for other indications than BAD in contrast to bile acid sequestrants
References: Hu W, Song R, Cheng R, Liu C, Guo R, Tang W, Zhang J, Zhao Q, Li X, Liu J
Glucagon-Like Peptide-1
Bowel Obstruction and Other GLP-1 GI Risks The FDA had received more than 1,200 reports of ileus and bowel obstructions from people taking Ozempic as of June 2026
Concurrent insulin or insulin secretagogue therapy
Ketoacidosis has also happened in people with diabetes who were sick or who had surgery during treatment with JARDIANCE